Figure 1D illustrates the histogram of log2 fold-change in the tumor and precancerous tissues of each GEJ cancer patient, demonstrating that the tumor expression specificity of CD66c was the highest among tested target candidates. This evidence concerns the gene CEACAM6 and neoplasm.